Literature DB >> 1591855

Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland.

D Steinberg1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591855     DOI: 10.1161/01.cir.85.6.2337

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  34 in total

Review 1.  Pathogenesis and pathology of coronary heart disease syndromes.

Authors:  P M Ridker; E M Antman
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

Review 2.  Did the antioxidant trials fail to validate the oxidation hypothesis?

Authors:  S Parthasarathy; N Khan-Merchant; M Penumetcha; B V Khan; N Santanam
Journal:  Curr Atheroscler Rep       Date:  2001-09       Impact factor: 5.113

Review 3.  Evidence based cardiology: emerging approaches in preventing cardiovascular disease.

Authors:  E M Lonn; S Yusuf
Journal:  BMJ       Date:  1999-05-15

4.  Low levels of soluble receptor for advanced glycation end products in non-ST elevation myocardial infarction patients.

Authors:  Erick D McNair; Calvin R Wells; A Mabood Qureshi; Rashpal S Basran; Colin Pearce; Jason Orvold; Jacobus Devilliers; Kailash Prasad
Journal:  Int J Angiol       Date:  2009

5.  Vitamin E does not slow the progression of hypercholesterolemic atherosclerosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2009

6.  Attenuation of the development of hypercholesterolemic atherosclerosis by thymoquinone.

Authors:  Ahmed Ragheb; Fawzy Elbarbry; Kailash Prasad; Adel Mohamed; Mohamed S Ahmed; Ahmed Shoker
Journal:  Int J Angiol       Date:  2008

Review 7.  Age-related changes affecting atherosclerotic risk. Potential for pharmacological intervention.

Authors:  L G Spagnoli; A Mauriello; A Orlandi; G Sangiorgi; E Bonanno
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

8.  Resveratrol, wine, and atherosclerosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2012-03

9.  Intact human ceruloplasmin oxidatively modifies low density lipoprotein.

Authors:  E Ehrenwald; G M Chisolm; P L Fox
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

Review 10.  Why are low-density lipoproteins atherogenic?

Authors:  S G Young; S Parthasarathy
Journal:  West J Med       Date:  1994-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.